
|Videos|May 26, 2022
Choosing a Combination Therapy for Renal Cell Carcinoma Before and After CLEAR Data
Author(s)Brian Shimkus, MD, Tom Powles, MBBS, MRCP, MD
Brian Shimkus, MD, discusses how he chose between RCC combination therapies before CLEAR trial data, and how the data influences his decisions now.
Advertisement
Episodes in this series

Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Daraxonrasib Shows "Unprecedented" Survival in Pretreated Pancreatic Cancer
2
Impact of IGNYTE Trial Responses to RP1/Nivolumab in Advanced Melanoma
3
FDA Receives sBLA for Zenocutuzumab in Advanced NRG1+ Cholangiocarcinoma
4
Navigating Proton Therapy, Immunotherapy Sequencing, and AI in HNC
5


































































